SCHEMBL5573221

SCHEMBL5573221

CC(S)CCCN=C=S

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27551595 0.91 NAAA (0.54) —
SCHEMBL27551593 0.91 NAAA (0.54) —
SCHEMBL4199374 0.86 — —
SCHEMBL1021255 0.81 — —
SCHEMBL6384757 0.76 TRPA1 (0.50) —
SCHEMBL30102626 0.73 NAAA (0.58) —
SCHEMBL30102642 0.73 NAAA (0.58) —
SCHEMBL25380794 0.72 NAAA (0.42) —
SCHEMBL364007 0.71 MIF (0.50) —
SCHEMBL15003957 0.71 NAAA (0.41) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1841320-A2 METHODS AND PHARMACEUTICAL COMPOSITIONS USEFUL FOR TREATING PSORIASIS S.U.L.V.E. Ltd. (IL) 2007-10-10 — — EP disclosed
WO-2006075330-A2 METHODS AND PHARMACEUTICAL COMPOSITIONS USEFUL FOR TREATING PSORIASIS S.U.L.V.E. LTD. (IL) 2006-07-20 — — WO disclosed
Send feedback